XIV Spanish Drug Discovery Network Meeting (Granada, 24-25th November)
On November 24-25th, Domingo Gargallo-Viola chaired the session on Antimicrobial Resistance and New Antibiotics in the XIV Spanish Drug Discovery Network Meeting that took place in Granada. In addition to Domingo Gargallo-Viola, Concepcion Gonzalez-Bello (University Santiago de Compostela), Sergio Lociuro (CSO Bioversys), and Rafael Canton Moreno (Hospital Ramon y Cajal, Madrid), gave different talks on one of the biggest global health challenges, […]
ABAC Therapeutics in collaboration with FNDR and Peptris lead an international project to develop new antibiotics against gram-negative bacteria
ABAC Therapeutics, together with the artificial intelligence (AI) company, Peptris, and the Foundation for Neglected Disease Research (FNDR), with scientific support from Medicines for Malaria Venture (MMV), leads an international project to optimize a new chemical structure that has shown effectiveness against Gram-negative bacteria, the greatest current threat to public health. In recent decades, there […]
Scientists search for molecules against antibiotic-resistant bacteria
Researchers from the Universitat Politècncia de Catalunya (UPC) and ABAC Therapeutics collaborate to develop new compounds and molecules designed to selectively attack bacteria resistant to current antibiotics. The new drugs will be respectful of the human bacterial flora making possible to combat the resistance of some of these pathogens «using an innovative approach» based on […]
